{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe inhibition constant (Ki) of a compound is the concentration of ligand in a radioligand binding inhibition assay that would occupy 50% of the transporters if no radioligand were present, with Ki values determined from radioligand binding studies with 3H-citalopram as described in Assay 1, and these Ki values are derived from IC50 values in the binding assay using the Cheng-Prusoff equation and the Ki of the radioligand (Cheng & Prusoff (1973) Biochem. Pharmacol. 22(23):3099-3108).\nCompounds of the invention of particular interest are those having a pKi at SERT greater than or equal to 5.0, particularly those having a pKi at SERT greater than or equal to 7.0, and even more particularly those having a pKi at SERT greater than or equal to 8.0, where pKi is the negative logarithm to base 10 of the Ki.\nAnother measure of serotonin reuptake inhibition is the pIC50 value, where compounds of interest are those having a serotonin reuptake inhibition pIC50 value greater than or equal to 5.0, particularly those having a pIC50 value greater than or equal to 7.0, and even more particularly those having a pIC50 value greater than or equal to 8.0."}
{"final_json": [{"molecule_name": null, "protein_target_name": "transporters", "binding_metric": "Ki", "value": null, "unit": null}, {"molecule_name": "compounds of the invention", "protein_target_name": "SERT", "binding_metric": "pKi", "value": ">= 5.0", "unit": null}, {"molecule_name": "compounds of the invention", "protein_target_name": "SERT", "binding_metric": "pKi", "value": ">= 7.0", "unit": null}, {"molecule_name": "compounds of the invention", "protein_target_name": "SERT", "binding_metric": "pKi", "value": ">= 8.0", "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "pIC50", "value": ">= 5.0", "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "pIC50", "value": ">= 7.0", "unit": null}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "pIC50", "value": ">= 8.0", "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nNone of the sentences in the provided text contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50 and their variations), a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "Non-specific uptake was determined in the presence of indatraline (2.5 \u03bc\u039c).\nNon-specific radioligand binding is determined in the presence of 1 \u03bc\u039c duloxetine.\nHomogenates are incubated for up to 5 minutes with <sup>3</sup>H-citalopram (3 nM) prior to termination of the assay by rapid filtration over a 96-well UniFilter GF/B plate, pretreated with 0.3% polyethyleneimine.\nNeurotransmitter Transporter Uptake Assay dye (0.5 \u03bc\u039c), and eleven different concentrations of compound ranging from 10 pM to 100 \u03bc\u039c was used."}
{"final_json": [{"molecule_name": "indatraline", "protein_target_name": null, "binding_metric": null, "value": "2.5", "unit": "\u03bc\u039c"}, {"molecule_name": "duloxetine", "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "\u03bc\u039c"}, {"molecule_name": "<sup>3</sup>H-citalopram", "protein_target_name": null, "binding_metric": null, "value": "3", "unit": "nM"}, {"molecule_name": "Neurotransmitter Transporter Uptake Assay dye", "protein_target_name": null, "binding_metric": null, "value": "0.5", "unit": "\u03bc\u039c"}, {"molecule_name": "compound", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "pM"}, {"molecule_name": "compound", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "\u03bc\u039c"}]}
